- Supply
- 45 g / stated three months
- Price
- $50/month equivalent; $150 per stated interval
- Named active
- Estriol
One M4 product, not the whole range
The selected M4 Face Cream Rx is described as an estriol-containing, fragrance-free face cream. The eye cream and serum are separate products. The provider says a clinician reviews an intake before prescribing.[source]
Check that the proposed item matches the research and instructions being discussed. A result involving one formulation should not be assumed to describe a bundle or a different application area.
Provider-reported findings require context
Alloy advertises a 12-week placebo comparison with changes in elasticity, hydration and other measures. It also says the product does not affect blood estrogen levels.[source]
These marketing statements do not establish zero exposure under every usage condition. Ask how the evidence relates to the complete preparation and your existing treatment. The conference-pilot discussion does not identify a retail-product match. Our retained FDA reference has not been freshly confirmed; the source note gives its historical date and access limit.
Price the actual delivery interval
On November 14, the face-cream page described 45 g for a stated three months, $50/month billed as $150 over that interval, and intake review without a separate charge. Those are provider terms, not a verified order or a promise that other Alloy services are included. [source]
Confirm the renewal date and support pathway rather than assuming all Alloy care is included. This option may be worth discussing within menopause-focused care, but a facial prescription should not be used as a self-directed substitute for treatment of systemic symptoms or as a reason to change an existing hormone regimen.
Looking for M4 eye cream?
Use the Alloy range discussion to identify the eye-page record before applying anything from this face-cream review. Keep the intended application area, complete formula and supporting report together. Do not transfer a concentration, instruction or outcome simply because two item names start with M4. This review remains about the face product.
For a study comparison, make a short evidence card: preparation, participants, comparator, measurement and follow-up. An empty field is a reason to ask for detail, not to fill it with information from another study. Keep a participant’s report of what they noticed separate from an instrument reading or an investigator’s grade. The claims guide develops that distinction without assigning an efficacy score to a product family.
For an order comparison, ask what the first payment buys and when the next decision must be made. A longer supply interval changes the timing of the commitment even when the headline is written monthly. The budget guide helps make that timing visible; it does not decide which prescription is clinically appropriate.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.
- Alloy: M4 Face Cream RxOfficial face-product material rechecked November 14, 2026; provider marketing is not independent clinical verification. · Checked November 14, 2026
- FDA: menopause and hormone questionsHistorical source record; the November 14, 2026 attempt did not retrieve substantive current text. Earlier observations retain their original dates. · Checked October 8, 2026